metformin has been researched along with natriuretic peptide, brain in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Dorkhan, M; Frid, A; Groop, L; Grubb, A; Jovinge, S; Magnusson, M | 1 |
| Balaska, A; Kakavas, N; Karagiannis, A; Koulas, G; Kountana, E; Sambanis, C; Tziomalos, K; Zamboulis, C; Zografou, I | 1 |
| Hu, M; Luo, Y; Tian, H; Wu, W; Zhang, H; Zhou, X | 1 |
| Burnier, M; Deleaval, P; Jornayvaz, FR; Maillard, M; Nussberger, J; Pechere-Bertschi, A; Vinciguerra, M; Zanchi, A | 1 |
| Li, L; Tao, HL; Wang, XF; Zhang, JY; Zhang, L; Zhao, XY | 1 |
| Gong, M; Liu, JH; Ma, AQ; Ni, YJ; Song, P; Wang, TZ; Wang, XH; Wei, F; Wu, Y; Yuan, Z; Zhuo, XZ | 1 |
| Czlonkowski, A; Filipiak, KJ; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E | 1 |
| Barrett-Connor, E; Christophi, CA; Davis, J; Florez, JC; Goldberg, RB; Horton, E; Jarolim, P; Ma, Y; Mather, KJ; Walford, GA; Wang, TJ | 1 |
| Brath, H; Clodi, M; Francesconi, C; Hülsmann, M; Luger, A; Neuhold, S; Pacher, R; Prager, R; Resl, M; Strunk, G; Vila, G; Wurm, R | 1 |
| Brandhorst, S; Cappello, F; Di Biase, S; Kim, KH; Lee, C; Longo, VD; Mirzaei, H; Rappa, F; Shim, HS; Vinciguerra, M; Wei, M | 1 |
| Dai, J; Ge, P; Huang, W; Lei, H; Lin, L; Liu, G; Luo, F; Wu, K; Zhang, L | 1 |
| Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM; Srivastava, PK | 1 |
| Fujita, M; Funada, J; Hasegawa, K; Horie, T; Inoue, H; Ogo, A; Ono, K; Satoh-Asahara, N; Shimatsu, A; Uehara, K; Wada, H | 1 |
| Gupta, DK; Jarolim, P; Ma, Y; Walford, GA; Wang, TJ | 1 |
| Kooy, A; Lehert, P; Schalkwijk, CG; Stehouwer, CDA; Top, WMC | 1 |
| Assa, S; Connelly, MA; de Koning, MLY; Dullaart, RPF; Garcia, E; Lipsic, E; van der Harst, P; van Veldhuisen, DJ; Westenbrink, BD | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Gunaparn, S; Leemasawat, K; Osataphan, N; Phrommintikul, A; Sirikul, W; Somwangprasert, A; Suksai, S | 1 |
9 trial(s) available for metformin and natriuretic peptide, brain
| Article | Year |
|---|---|
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
Topics: Adiponectin; Administration, Oral; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pioglitazone; Proinsulin; Prospective Studies; Statistics, Nonparametric; Thiazolidinediones | 2006 |
[Effect of insulin plus rosiglitazone or metformin on serum N-terminal pro-brain natriuretic peptide in type 2 diabetes mellitus: a randomized-controlled study].
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Rosiglitazone; Thiazolidinediones | 2008 |
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals.
Topics: Analysis of Variance; Blood Pressure; Body Weight; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Natriuretic Peptide, Brain; Pioglitazone; Sodium, Dietary; Thiazolidinediones | 2010 |
Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Topics: Adipose Tissue; Adiposity; Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Insulin Resistance; Life Style; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Obesity; Peptide Fragments; Regression Analysis | 2014 |
Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Glargine; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Risk Factors; Troponin T | 2017 |
Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial.
Topics: Aged; Body Mass Index; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Heart Ventricles; Humans; Hypertension; Hypoglycemic Agents; Male; Metformin; Natriuretic Peptide, Brain; Organ Size; Treatment Outcome; Ventricular Function, Left | 2020 |
Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments | 2021 |
Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
Topics: Aged; Biomarkers; Female; Humans; Hypoglycemic Agents; Ketone Bodies; Male; Metformin; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Recovery of Function; ST Elevation Myocardial Infarction; Stroke Volume | 2021 |
Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial.
Topics: Breast Neoplasms; Cardiotoxicity; Donepezil; Doxorubicin; Female; Humans; Leukocytes, Mononuclear; Metformin; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Ventricular Function, Left | 2023 |
8 other study(ies) available for metformin and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Humans; Hypoglycemic Agents; Lipids; Liver Function Tests; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pioglitazone; Thiazolidinediones | 2008 |
Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Echocardiography; Heart Failure; Hypoglycemic Agents; Insulin; Male; Metformin; Myocardium; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Ribonucleotides; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heart Failure; Isoproterenol; Male; Metformin; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |
Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Aged; Atherosclerosis; Biguanides; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diuretics; Female; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prevalence; Risk Factors | 2013 |
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
Topics: Aged; Austria; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Proportional Hazards Models; Prospective Studies; Protective Factors; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2016 |
Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Atrial Natriuretic Factor; Cardiotoxins; Cyclic AMP-Dependent Protein Kinases; Cytoprotection; Dexamethasone; Diet; Early Growth Response Protein 1; Fasting; Female; Glucose; Hyperglycemia; Metformin; Mice; Mice, Inbred C57BL; Natriuretic Peptide, Brain; Stress, Physiological; Time Factors | 2017 |
Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK.
Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cytokines; Heart; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Metformin; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Peroxidase | 2017 |
Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention Program.
Topics: Adult; Diabetes Mellitus, Type 2; Ethnicity; Female; Humans; Life Style; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Peptide Fragments; Racial Groups; Randomized Controlled Trials as Topic | 2020 |